Negative in Ames, in vitro human lymphocyte micronucleus, in vivo rat bone marrow micronucleus and rat comet assays
“Serdexmethylphenidate was not mutagenic in the in vitro Ames reverse mutation assay, in the in vitro mammalian cell micronucleus assay using human peripheral blood lymphocytes, in the in vivo rat bone barrow micronucleus assay, or in the in vivo rat alkaline comet assay.”
Not conducted with SDX; relies on referenced d-MPH (Focalin XR) labeling
“Carcinogenicity studies were not conducted with SDX. The Applicant is relying upon the carcinogenicity data in the referenced product labeling.”
✓ VerifiedFDA multi-discipline review, p. 61Source ↗
Reproductive & developmental
Rabbit EFD: no maternal or fetal developmental toxicity up to 49x MRHD (400 mg/kg)
“In the embryo-fetal development study in rabbits, there were no findings of maternal or fetal development toxicity at exposures up to 49 times (400 mg/kg) the MRHD.”
✓ VerifiedFDA multi-discipline review, p. 45Source ↗
Safety pharmacology
CNS, hERG, cardiovascular and respiratory battery: stimulant-type effects comparable to d-MPH; hERG IC50 >25 uM
“All findings for SDX were typical of a CNS stimulant (including dilated pupil, increased activity, increased heart rate and blood pressure, and increased respiratory rate) and all findings were generally comparable for SDX and a comparative dose of d-MPH. In the hERG assay, the IC50 for SDX was considered >25 µM.”
✓ VerifiedFDA multi-discipline review, p. 48Source ↗
Not genotoxic overall: Ames negative; in vitro chromosome aberration positive without (not with) metabolic activation; rat micronucleus and comet negative